ALMI Invest, together with Första Entreprenörsfonden, has invested SEK 2 million (€218,000) in Sprint Bioscience, a drug development services company specialising in lead generation.
The company carries out commissioned research for the pharmaceutical industry, and is also working to develop its own lead compounds.Never miss an update from Science|Business: Newsletter sign-up
Receive our Policy Bulletin each Tuesday & Thursday and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
